| Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case–noncase study in the French Pharmacovigilance Database J Béné, G Moulis, I Bennani, M Auffret, P Coupe, S Babai, D Hillaire‐Buys, ... British Journal of Dermatology 175 (2), 296-301, 2016 | 182 | 2016 |
| Bullous pemphigoid induced by vildagliptin: a report of three cases J Béné, A Jacobsoone, P Coupe, M Auffret, S Babai, D Hillaire‐Buys, ... Fundamental & Clinical Pharmacology 29 (1), 112-114, 2015 | 81 | 2015 |
| Baclofen for alcohol dependence: relationships between baclofen and alcohol dosing and the occurrence of major sedation B Rolland, J Labreuche, A Duhamel, S Deheul, S Gautier, M Auffret, ... European Neuropsychopharmacology 25 (10), 1631-1636, 2015 | 68 | 2015 |
| Baclofen-induced manic symptoms: case report and systematic review PA Geoffroy, M Auffret, S Deheul, R Bordet, O Cottencin, B Rolland Psychosomatics 55 (4), 326-332, 2014 | 50 | 2014 |
| Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database J Bene, G Moulis, M Auffret, G Lefevre, P Coquerelle, P Coupe, P Pere, ... Rheumatology 53 (8), 1465-1469, 2014 | 37 | 2014 |
| Misoprostol exposure during the first trimester of pregnancy: Is the malformation risk varying depending on the indication? M Auffret, N Bernard-Phalippon, J Dekemp, P Carlier, MG Boyer, T Vial, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 207 …, 2016 | 34 | 2016 |
| Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study B Rolland, T Valin, C Langlois, M Auffret, S Gautier, S Deheul, T Danel, ... International clinical psychopharmacology 30 (1), 49-53, 2015 | 31 | 2015 |
| The PREGVAXGRIP Study: a Cohort Study to Assess Foetal and Neonatal Consequences of In Utero Exposure to Vaccination Against A(H1N1)v2009 Influenza F Chavant, I Ingrand, AP Jonville-Bera, C Plazanet, V Gras-Champel, ... Drug safety 36, 455-465, 2013 | 31 | 2013 |
| Unexpected platelets elevation in a patient with idiopathic thrombocytopenia treated with oseltamivir for influenza infection P Bigot, M Auffret, S Gautier, M Weinborn, NK Ettahar, P Coupé Fundamental & Clinical Pharmacology 30 (5), 483-485, 2016 | 30 | 2016 |
| Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis M Nourredine, L Jurek, M Auffret, S Iceta, G Grenet, B Kassai, M Cucherat, ... CNS spectrums 26 (5), 459-467, 2021 | 27 | 2021 |
| Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: an example with … M Auffret, J Labreuche, A Duhamel, S Deheul, O Cottencin, R Bordet, ... Drug safety 40, 257-262, 2017 | 26 | 2017 |
| Severe tinnitus induced by off-label baclofen M Auffret, B Rolland, S Deheul, V Loche, C Hennaux, O Cottencin, ... Annals of Pharmacotherapy 48 (5), 656-659, 2014 | 26 | 2014 |
| Safety profile of etifoxine: A French pharmacovigilance survey J Cottin, A Gouraud, MJ Jean‐Pastor, AD Dautriche, C Boulay, H Geniaux, ... Fundamental & Clinical Pharmacology 30 (2), 147-152, 2016 | 22 | 2016 |
| French Association of Regional PharmacoVigilance Centres. Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case–noncase study in the French Pharmacovigilance Database J Béné, G Moulis, I Bennani, M Auffret, P Coupe, S Babai, D Hillaire-Buys, ... Br J Dermatol 175 (2), 296-301, 2016 | 21 | 2016 |
| Acute myocarditis induced by hypomethylating agents. JE Bibault, N Cambier, JM Lemahieu, B Quesnel, M Auffret, C Rose Journal of Clinical Oncology: Official Journal of the American Society of …, 2011 | 18 | 2011 |
| Clomiphene citrate and neural tube defects: A meta‐analysis of controlled observational studies M Auffret, J Cottin, T Vial, M Cucherat BJOG: An International Journal of Obstetrics & Gynaecology 126 (9), 1127-1133, 2019 | 17 | 2019 |
| Guillain–Barré syndrome associated with COVID-19 vaccines: a perspective from spontaneous report data M Atzenhoffer, M Auffret, A Pegat, K Masmoudi, C Khouri, B Bertin, T Vial Clinical Drug Investigation 42 (7), 581-592, 2022 | 16 | 2022 |
| Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database M Rochoy, M Auffret, J Bene, S Gautier Revue D'epidemiologie et de Sante Publique 65 (1), 1-8, 2016 | 16 | 2016 |
| DPP-4 inhibitors and respiratory infection: a systematic review and meta-analysis of the cardiovascular outcomes trials G Grenet, S Mekhaldi, S Mainbourg, M Auffret, C Cornu, JL Cracowski, ... Diabetes Care 44 (3), e36-e37, 2021 | 15 | 2021 |
| The dose–effect relationship of baclofen in alcohol dependence: A 1‐year cohort study B Pignon, J Labreuche, M Auffret, S Gautier, S Deheul, N Simioni, ... Human Psychopharmacology: Clinical and Experimental 32 (4), e2593, 2017 | 15 | 2017 |
Benjamin ROLLANDUniv. Lyon 1, Hospices Civils de Lyon, CH Vinatier, SUAL (Service Universitaire d'Addictologie deVerified email at univ-lyon1.fr
